Urinary Phosphate-Containing Nanoparticle Contributes to Inflammation and Kidney Injury in a Salt-Sensitive Hypertension Rat Model

Qin Wang,Kenichi Ishizawa,Jinping Li,Wataru Fujii,Yoshikazu Nemoto,Osamu Yamazaki,Yoshifuru Tamura,Yutaka Miura,Xuedan Nie,Ryo Abe,Hiroko Segawa,Makoto Kuro-O,Shigeru Shibata

DOI: https://doi.org/10.1038/s42003-020-01298-1

IF: 6.548

2020-01-01

Communications Biology

Abstract:Although disturbed phosphate metabolism frequently accompanies chronic kidney disease (CKD), its causal role in CKD progression remains unclear. It is also not fully understood how excess salt induces organ damage. We here show that urinary phosphate-containing nanoparticles promote kidney injury in salt-sensitive hypertension. In Dahl salt-sensitive rats, salt loading resulted in a significant increase in urinary phosphate excretion without altering serum phosphate levels. An intestinal phosphate binder sucroferric oxyhydroxide attenuated renal inflammation and proteinuria in this model, along with the suppression of phosphaturia. Using cultured proximal tubule cells, we confirmed direct pathogenic roles of phosphate-containing nanoparticles in renal tubules. Finally, transcriptome analysis revealed a potential role of complement C1q in renal inflammation associated with altered phosphate metabolism. These data demonstrate that increased phosphate excretion promotes renal inflammation in salt-sensitive hypertension and suggest a role of disturbed phosphate metabolism in the pathophysiology of hypertensive kidney disease and high salt-induced kidney injury. Qin Wang et al. show that altered phosphate metabolism contributes to the progression of kidney disease using a salt-sensitive rat model. They demonstrate that using the phosphate binder sucroferric oxyhydroxide reduces kidney injury and, using transcriptome sequencing, identify a potential role for complement C1q in kidney inflammation linked to phosphate metabolism defects.